|
|
Article: Japan's Biotech Business Market to Top US$202 billion by 2010.(Statistical Data Included)
- Article from:
- Japanese Biotechnology & Medical Technology
- Article date:
- April 1, 2001
CopyrightCOPYRIGHT 2001 Newmedia International Japan. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Having thrown away an early lead in biotech research, and been rudely awakened by the success of the Human Genome Project, in which the USA has been the main beneficiary, Japan's government ministers are rallying backup, including finance, to help secure a main international ranking in the business bonanza they now predict will happen.
Apart from assessing business market values in Japan reaching US$ 202 billion, there is much talk in government circles of a thousand new biotech enterprises being established.
There has been a recognition in Japanese biotech circles, state and private that the way ahead is to focus exploitation on complementary DNA (cDNA) ...